Compare Stocks › ADBE vs MRNA
Adobe Inc. (ADBE) vs Moderna, Inc. (MRNA)
ADBE
Adobe Inc.
$245.99
VS
MRNA
Moderna, Inc.
$52.37
Rewards
ADBE
- ★Adobe Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
- ★Gross margin of 89.4% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
- ★Adobe Inc. scores 100/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
MRNA
Risks
ADBE
MRNA
- ⚠ROIC has declined by 61.0 percentage points over the observed period, which may signal competitive erosion.
- ⚠Gross margin of -105.8% is low, suggesting a competitive or commodity-like market with limited pricing power.
- ⚠Moderna, Inc. scores only 17/100 on the Economic Moat Score, suggesting limited durable competitive advantages.
Key Valuation Metrics
Learn more →ADBE
MRNA
Valuation
$9.29B
Free Cash Flow
$-1.33B
9.20%
FCF Yield
-6.41%
14.33
Trailing P/E
N/A
9.33
Forward P/E
-11.51
Quality & Moat
40.36%
ROIC
-19.50%
62.36%
ROE
-32.62%
89.40%
Gross Margin
-105.76%
1.29
PEG Ratio
N/A
Balance Sheet Safety
0.58
Debt / Equity
0.15
N/A
Interest Coverage
N/A
-0.02
Net Debt / EBITDA
N/A
N/A
Dividend Yield
N/A
ADBE: 5Ties: 1MRNA: 2
ADBEMRNA
Historical Fundamentals
Learn more →ADBE
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.
MRNA
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.
$1 Retained Earnings Test
Learn more →ADBE
$-0.60
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$18.12B
Δ Market Cap
$-10.93B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
MRNA
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-11.10B
Δ Market Cap
$-57.53B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Discounted Cash Flow (DCF) Analysis
Learn more →ADBE
48.4% Margin of Safety
Price is 48.4% below estimated fair value
Current Price: $245.99
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
Fair Value: $477.11
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
MRNA
Insufficient Data
Enter initial FCF to calculate intrinsic value
Current Price: $52.37
Strongly undervalued
Strongly overvalued
Fair Value: $0.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
Reverse DCF — Market-Implied Growth
Learn more →ADBE
What growth rate is the market pricing in at $246?
+3.0%
Market-Implied Owner Earnings Growth
Standard FCF implies -0.7%
The market implies +3.0% Owner Earnings growth, below historical trends — potential opportunity.
Standard FCF implies a more demanding -0.7%, reflecting heavy growth investment expected to generate future returns.
MRNA
Requires positive FCF to compute implied growth rate.
Economic Moat Score
Learn more →ADBE
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None
Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.
Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
MRNA
17/100
No Moat
70+ Wide · 40-69 Narrow · <40 None
No durable competitive advantage detected. The business shows limited evidence of pricing power, consistent returns, or capital efficiency.
Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
Forensic Accounting
Learn more →ADBE
-2.85
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
MRNA
-3.72
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Ownership Breakdown
Learn more →ADBE
Insiders 0.2%Institutions 87.8%Retail & Other 11.9%
No. of Institutional Holders3,534
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
MRNA
Insiders 7.3%Institutions 77.1%Retail & Other 15.5%
No. of Institutional Holders978
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.
Insider Buying Activity
Learn more →ADBE
0
Buys (3M)
0
Buys (12M)
DURN DANIEL J
Chief Financial Officer
$507,758
@ $390.58 · 2025-03-20
RICKS DAVID A
Director
$998,946
@ $443.98 · 2025-01-28
Open market purchases · includes direct & indirect ownership · excludes option exercises
MRNA
0
Buys (3M)
0
Buys (12M)
SAGAN PAUL L
Director
$1.00M
@ $31.76 · 2025-03-03
BANCEL STEPHANE J
Chief Executive Officer
$5.00M
@ $31.22 · 2025-03-03
Open market purchases · includes direct & indirect ownership · excludes option exercises
Open market purchases · includes direct & indirect ownership · excludes option exercises.
Insider Selling Activity
Learn more →ADBE
1
Sells (3M)
3
Sells (12M)
Total value (12M): $711,495
DURN DANIEL J
Chief Financial Officer
$485,323
@ $294.85 · 2026-01-27
FORUSZ JILLIAN
Officer
$50,344
@ $337.88 · 2025-10-31
FORUSZ JILLIAN
Officer
$175,828
@ $380.58 · 2025-05-02
FORUSZ JILLIAN
Officer
$145,567
@ $435.83 · 2025-01-28
BELSKY SCOTT K
Officer
$2.05M
@ $431.61 · 2025-01-27
BANSE AMY L
Director
$333,300
@ $550.00 · 2024-12-06
FORUSZ JILLIAN
Officer
$327,987
@ $485.19 · 2024-10-29
BELSKY SCOTT K
Officer
$232,525
@ $483.42 · 2024-10-25
BELSKY SCOTT K
Officer
$1.14M
@ $511.48 · 2024-10-16
DURN DANIEL J
Chief Financial Officer
$3.35M
@ $515.44 · 2024-09-17
GARFIELD MARK S.
Officer
$52,089
@ $537.00 · 2024-07-25
BELSKY SCOTT K
Officer
$258,297
@ $537.00 · 2024-07-25
GARFIELD MARK S.
Officer
$85,255
@ $564.60 · 2024-07-16
BELSKY SCOTT K
Officer
$1.25M
@ $561.60 · 2024-07-16
RAO DANA J.D.
General Counsel
$3.56M
@ $525.51 · 2024-06-17
GARFIELD MARK S.
Officer
$138,735
@ $525.51 · 2024-06-17
GARFIELD MARK S.
Officer
$265,644
@ $447.97 · 2024-06-03
GARFIELD MARK S.
Officer
$389,630
@ $490.10 · 2024-05-06
BELSKY SCOTT K
Officer
$1.29M
@ $474.30 · 2024-05-02
GARFIELD MARK S.
Officer
$45,436
@ $468.41 · 2024-04-25
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
MRNA
2
Sells (3M)
4
Sells (12M)
Total value (12M): $8.56M
KLINGER SHANNON THYME
Officer
$726,047
@ $52.29 · 2026-03-02
HOGE STEPHEN
President
$7.81M
@ $48.84 · 2026-02-23
HUSSAIN SHAH ABBAS
Director
$13,910
@ $27.60 · 2025-12-09
HUSSAIN SHAH ABBAS
Director
$8,736
@ $28.00 · 2025-06-11
KLINGER SHANNON THYME
Officer
$23,637
@ $44.68 · 2024-12-09
HOGE STEPHEN
President
$13,595
@ $43.30 · 2024-12-03
KLINGER SHANNON THYME
Officer
$4,849
@ $43.29 · 2024-12-03
HOGE STEPHEN
President
$12,452
@ $42.79 · 2024-11-29
MOCK JAMES M
Chief Financial Officer
$60,761
@ $42.79 · 2024-11-29
KLINGER SHANNON THYME
Officer
$60,675
@ $42.79 · 2024-11-29
HOGE STEPHEN
President
$12,771
@ $46.10 · 2024-11-11
MOCK JAMES M
Chief Financial Officer
$42,986
@ $60.12 · 2024-10-07
KLINGER SHANNON THYME
Officer
$40,539
@ $73.57 · 2024-09-09
HOGE STEPHEN
President
$24,483
@ $76.99 · 2024-09-03
KLINGER SHANNON THYME
Officer
$8,777
@ $76.99 · 2024-09-03
HOGE STEPHEN
President
$23,408
@ $78.03 · 2024-08-29
MOCK JAMES M
Chief Financial Officer
$12,640
@ $78.02 · 2024-08-29
KLINGER SHANNON THYME
Officer
$12,640
@ $78.02 · 2024-08-29
MOCK JAMES M
Chief Financial Officer
$104,881
@ $79.40 · 2024-08-28
KLINGER SHANNON THYME
Officer
$104,722
@ $79.39 · 2024-08-28
HOGE STEPHEN
President
$21,363
@ $84.11 · 2024-08-12
AFEYAN NOUBAR BOGHOS
Director
$1.80M
@ $119.96 · 2024-07-31
AFEYAN NOUBAR BOGHOS
Director
$1.77M
@ $117.80 · 2024-07-24
AFEYAN NOUBAR BOGHOS
Director
$1.84M
@ $122.84 · 2024-07-17
HOGE STEPHEN
President
$1.82M
@ $121.12 · 2024-07-15
AFEYAN NOUBAR BOGHOS
Director
$1.76M
@ $117.08 · 2024-07-10
MOCK JAMES M
Chief Financial Officer
$81,465
@ $118.24 · 2024-07-08
AFEYAN NOUBAR BOGHOS
Director
$1.91M
@ $127.22 · 2024-06-26
AFEYAN NOUBAR BOGHOS
Director
$2.00M
@ $133.57 · 2024-06-18
HOGE STEPHEN
President
$2.07M
@ $138.16 · 2024-06-17
AFEYAN NOUBAR BOGHOS
Director
$2.21M
@ $147.20 · 2024-06-12
KLINGER SHANNON THYME
Officer
$766,785
@ $148.09 · 2024-06-10
AFEYAN NOUBAR BOGHOS
Director
$2.27M
@ $151.25 · 2024-06-05
HOGE STEPHEN
President
$47,704
@ $140.72 · 2024-06-03
MOCK JAMES M
Chief Financial Officer
$97,237
@ $140.72 · 2024-06-03
KLINGER SHANNON THYME
Officer
$17,168
@ $140.72 · 2024-06-03
AFEYAN NOUBAR BOGHOS
Director
$2.90M
@ $145.08 · 2024-05-29
HOGE STEPHEN
President
$49,276
@ $144.50 · 2024-05-29
MOCK JAMES M
Chief Financial Officer
$26,444
@ $144.50 · 2024-05-29
KLINGER SHANNON THYME
Officer
$26,444
@ $144.50 · 2024-05-29
MOCK JAMES M
Chief Financial Officer
$105,283
@ $162.47 · 2024-05-28
KLINGER SHANNON THYME
Officer
$210,566
@ $162.47 · 2024-05-28
AFEYAN NOUBAR BOGHOS
Director
$2.36M
@ $157.57 · 2024-05-22
AFEYAN NOUBAR BOGHOS
Director
$1.91M
@ $127.32 · 2024-05-15
HOGE STEPHEN
President
$1.91M
@ $127.49 · 2024-05-15
HOGE STEPHEN
President
$30,844
@ $120.96 · 2024-05-10
AFEYAN NOUBAR BOGHOS
Director
$1.83M
@ $121.68 · 2024-05-08
AFEYAN NOUBAR BOGHOS
Director
$1.66M
@ $110.92 · 2024-05-01
AFEYAN NOUBAR BOGHOS
Director
$1.62M
@ $108.32 · 2024-04-24
AFEYAN NOUBAR BOGHOS
Director
$1.55M
@ $103.38 · 2024-04-17
HOGE STEPHEN
President
$1.58M
@ $105.02 · 2024-04-15
AFEYAN NOUBAR BOGHOS
Director
$1.61M
@ $107.12 · 2024-04-10
MOCK JAMES M
Chief Financial Officer
$71,859
@ $101.93 · 2024-04-08
AFEYAN NOUBAR BOGHOS
Director
$1.53M
@ $101.68 · 2024-04-03
AFEYAN NOUBAR BOGHOS
Director
$1.64M
@ $109.06 · 2024-03-27
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.
🎭 Mr. Market's Mood
Learn more →ADBE
😨Fear(27/100)
"Market is pessimistic — investigate whether fears are temporary or structural"
Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
MRNA
😐Neutral(47/100)
"Market is pricing this stock without strong emotion in either direction"
Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
⚖️ Buffett Signal
Learn more →ADBE
⚪Awaiting DCF Data
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
DCF Margin of Safety: N/AMr. Market's Mood: Fear (27)
MRNA
⚪Awaiting DCF Data
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)